COVID-19 vaccine-induced guillain-barre syndrome
First case of severe acute respiratory syndrome coronavirus-2 was detected in Wuhan province of china. Within a year, the vaccine development process accelerated and emergency approval was rolled out for vaccines. Covishield, an adenovirus vector-based vaccine manufactured by Serum Institute of Indi...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wolters Kluwer Medknow Publications
2024-01-01
|
| Col·lecció: | Journal of the Scientific Society |
| Matèries: | |
| Accés en línia: | http://www.jscisociety.com/article.asp?issn=0974-5009;year=2024;volume=51;issue=1;spage=105;epage=107;aulast=Sajan |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|